
c-Myc
Os inibidores de c-Myc têm como alvo a proteína c-Myc, um fator de transcrição que desempenha um papel crucial no crescimento celular, proliferação e apoptose. c-Myc regula a expressão de numerosos genes envolvidos no ciclo celular e é frequentemente superexpresso em vários tipos de câncer, levando a uma proliferação celular descontrolada e ao crescimento tumoral. Inibir o c-Myc pode interromper esses processos, induzindo a parada do ciclo celular e a apoptose em células cancerígenas. Os inibidores de c-Myc são ferramentas importantes na pesquisa do câncer e no desenvolvimento terapêutico. Na CymitQuimica, oferecemos uma ampla gama de inibidores de c-Myc de alta qualidade para apoiar sua pesquisa em oncologia, regulação do ciclo celular e controle transcricional.
Foram encontrados 76 produtos de "c-Myc"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Eragidomide
CAS:Eragidomide (Cereblon modulator 1) is a CRBN E3 ligase modulator, specifically binds to CRBN, thereby affecting the activity of the ubiquitin E3 ligase complex.Fórmula:C22H18ClF2N3O4Pureza:97.51% - 99.63%Cor e Forma:SolidPeso molecular:461.85Ref: TM-T10765
1mg38,00€5mg82,00€10mg133,00€25mg269,00€50mg442,00€100mg595,00€200mg802,00€1mL*10mM (DMSO)84,00€Saxagliptin hydrate
CAS:Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).Fórmula:C18H25N3O2·H2OPureza:99.52%Cor e Forma:SolidPeso molecular:333.43MYCi975
CAS:MYCi975 (NUCC-0200975) is an orally active inhibitor of MYC.Fórmula:C25H16Cl2F6N2O2Pureza:99.3% - 99.82%Cor e Forma:SolidPeso molecular:561.3FIDAS-5
CAS:FIDAS-5 is an orally active methionine adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM. Cost-effective and quality-assured.Fórmula:C15H13ClFNPureza:98.3% - 99.17%Cor e Forma:SolidPeso molecular:261.72Ref: TM-T11285
1mg59,00€2mg85,00€5mg116,00€10mg187,00€25mg331,00€50mg512,00€100mg740,00€500mg1.415,00€MYCi361
CAS:MYCi361 (NUCC-0196361) is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM).Fórmula:C26H16ClF9N2O2Pureza:99.52%Cor e Forma:SolidPeso molecular:594.86MYCMI-6
CAS:MYCMI-6 inhibits MYC:MAX, reduces tumor growth, triggers apoptosis, minimal side effects.Fórmula:C20H19N7OPureza:99.23%Cor e Forma:SolidPeso molecular:373.41Ref: TM-T12134
1mg71,00€5mg152,00€10mg222,00€25mg358,00€50mg512,00€100mg707,00€200mg973,00€500mg1.431,00€Ceramides Mixture
CAS:Ceramides Mixture: endogenous, regulates cell cycle, growth, and telomerase activity, with hydroxy/non-hydroxy fatty acids.Fórmula:C36H71NO4Pureza:98%Cor e Forma:SolidPeso molecular:581.967KJ Pyr 9
CAS:KJ Pyr 9 is an MYC inhibitor (Kd: 6.5 nM in vitro assay).Fórmula:C22H15N3O4Pureza:99.56% - ≥98%Cor e Forma:SolidPeso molecular:385.37Ref: TM-T15665
2mg37,00€5mg54,00€10mg77,00€25mg138,00€50mg264,00€100mg482,00€200mg647,00€500mg1.009,00€1mL*10mM (DMSO)59,00€FIDAS-3
CAS:FIDAS-3, a stilbene derivative and potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A), exhibits anticancer activitiesFórmula:C16H15F2NPureza:97.75%Cor e Forma:SolidPeso molecular:259.29Ref: TM-T11284
5mg49,00€10mg73,00€25mg127,00€50mg182,00€100mg264,00€200mg354,00€1mL*10mM (DMSO)48,00€APTO-253
CAS:APTO-253 (LOR-253) inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells.Fórmula:C22H14FN5Pureza:98.73%Cor e Forma:SolidPeso molecular:367.38Ref: TM-T10352
1mg40,00€2mg52,00€5mg75,00€10mg96,00€25mg170,00€50mg255,00€100mg371,00€1mL*10mM (DMSO)84,00€WBC100
CAS:WBC100 (14-D-Valine-TPL) is a potent, selective, and orally active c-Myc glue degrader that targets the ubiquitin E3 ligase CHIP-mediated 26S proteasome pathwayFórmula:C25H33NO7Pureza:98%Cor e Forma:SolidPeso molecular:459.53MDEG-541
MDEG-541 is a potent MYC-MAX degrader that exhibits antiproliferative activity by downregulating the expression of GSPT1, MYC, GSPT2, and PLK1 proteins [1].Fórmula:C35H38N4O7SPureza:98%Cor e Forma:SolidPeso molecular:658.76PROTAC MTP3 degrade-1
PROTACMTP3 degrade-1 is a PROTAC degrader for MYC.Fórmula:C44H38N6O8Cor e Forma:SolidPeso molecular:778.27511Methylcarbamyl PAF C-8
Methylcarbamyl PAF C-8 is resistant to degradation by PAF-AH and has a half-life of over 100 minutes in platelet-poor plasma, exhibiting platelet aggregation activity. In NRK-49 cells overexpressing PAF receptor, it induces the expression of c-myc, c-fos, and activates mitogen-activated protein kinase (MAPK). Furthermore, Methylcarbamyl PAF C-8 can induce G1 phase cell cycle arrest. This compound shows potential for research in cardiovascular and anti-cancer applications.Cor e Forma:Odour Solidc-Myc inhibitor 11
c-Myc inhibitor 11 (Compound 67e), a c-MYC inhibitor (p EC 50 : 6.4), exhibits high clearance, a moderate volume of distribution, and a short half-life in ratFórmula:C20H22N6OPureza:98%Cor e Forma:SolidPeso molecular:362.43c-Myc inhibitor 12
Compound 67h, also known as c-Myc inhibitor 12, is a potent inhibitor of c-Myc, exhibiting a pEC50 value of 6.4 [1].Fórmula:C22H24N6OPureza:98%Cor e Forma:SolidPeso molecular:388.47Anticancer agent 263
Anticanceragent 263 (compound 7) is an effective anticancer agent. It binds with the G-quadruplex DNA (G4) sequence 22-mer Pu22 (a c-Myc DNA analog). As a structural modulator, Anticanceragent 263 significantly enhances the formation of protein α-helices and has the capacity to form a supramolecular network. Furthermore, Anticanceragent 263 exhibits no cytotoxicity.Fórmula:C13H20N2O6Cor e Forma:SolidPeso molecular:300.308c-Myc inhibitor 7
CAS:c-Myc inhibitor 7 degrades c-MYC, CK1α, GSPT1, IKZF1/2/3 proteins in tumors, for research on related diseases.Fórmula:C35H30N6O5Cor e Forma:SoildPeso molecular:614.65MYC-IN-2
CAS:MYC-IN-2 is a protein-protein inhibitor targeting the MYC protein, designed for use in cancer research.Fórmula:C25H17N3O2SCor e Forma:SolidPeso molecular:423.49RA-V
RA-V is a natural product that can be used as a reference standard.Fórmula:C160H202N24O41Cor e Forma:SolidPeso molecular:3117.5c-Myc inhibitor 5
DA3: Fluorescent c-Myc inhibitor, targets c-MYC G-quadruplex (K D 16 μM), selective, suppresses c-MYC expression.Fórmula:C30H46N12Cor e Forma:SolidPeso molecular:574.77c-Myc inhibitor 10
CAS:c-Myc inhibitor 10 enhances cell potency with improved permeability from methylated morpholine nitrogen.Fórmula:C28H38N6O3Cor e Forma:SolidPeso molecular:506.64Anticancer agent 84
CAS:Anticancer agent 84 inhibits c-MYC transcription by stabilizing G4 structures, aiding cancer research.Fórmula:C57H67N7O9Cor e Forma:SolidPeso molecular:994.18VGN50
VGN50 is a bioactive molecule that mimics the function of K-Rta, capable of downregulating MYC-mediated gene transcription. VGN50 exhibits antitumor activity.Fórmula:C121H218N46O32Peso molecular:2827.68453c-Myc inhibitor 13
c-Myc inhibitor13 (compound A6) is an inhibitor of c-MYC transcription. It selectively stabilizes c-MYCG4 and inhibits G4-related c-MYC transcription.Fórmula:C30H39N9OPeso molecular:541.32776CSI86
CSI86 is a PROTAC degrader targeting MYC, exhibiting antiproliferative activity (IC50: 13-18 μM).Fórmula:C48H50F9N7O7SCor e Forma:SolidPeso molecular:1040Cotylenin A
CAS:Cotylenin A is a phenanthraquinone compound that synergistically works with vitamin K2 to induce monocyte differentiation and growth arrest. It also inhibits c-Myc expression while inducing cyclin G2 expression in human leukemia HL-60 cells. Cotylenin A is applicable in acute myeloid leukemia research.Fórmula:C33H50O11Cor e Forma:SolidPeso molecular:622.744H122
H122 is a TEADPROTAC degrader effective in degrading TEAD1 with a DC50 of 3 nM, and it shows strong affinity for TEAD2, TEAD3, and TEAD4 with Ki values of 2.0, 3.6, and 1.6 nM, respectively. H122 also downregulates Myc expression and inhibits the growth of MSTO-211H and NCI-H226 cells, with IC50 values of 21.3 nM and 0.6 nM, respectively, demonstrating antitumor activity in mouse models. (Pink: ligand for target protein; Black: linker; Blue: ligand for E3 ligaseCereblon)Fórmula:C45H45ClFN5O8Cor e Forma:SolidPeso molecular:838.319VPC-70063
CAS:VPC-70063 (Thiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)-) is an inhibitor of c-Myc-MAX.Fórmula:C16H12F6N2SPureza:99.98%Cor e Forma:SolidPeso molecular:378.34Ref: TM-T60019
1mg49,00€5mg101,00€10mg152,00€25mg268,00€50mg385,00€100mg560,00€200mg790,00€1mL*10mM (DMSO)130,00€VTX-0811
VTX-0811 is a human IgG4 monoclonal antibody (mAb) that targets PSGL1/CD162. It modulates immune signaling pathways by enhancing TNF-α/NF-κB and chemokine-mediated signaling while reducing oxidative phosphorylation, fatty acid metabolism, and Myc signaling. VTX-0811 increases the proportion of CD8+ T cells among infiltrating T cells and exhibits antitumor activity in humanized mouse PDX models of melanoma.Cor e Forma:Odour LiquidKL4-219A
KL4-219A is a selective covalent degrader of the MYC, inhibiting MYC transcriptional activity and degrading MYC in a proteasome-dependent manner .Fórmula:C20H22N2O3SPureza:99.68%Cor e Forma:SolidPeso molecular:370.47PROTAC LZK-IN-1
CAS:PROTAC LZK-IN-1 (Compound 21A) is a PROTAC molecule that targets the degradation of LZK (leucine zipper kinase, encoded by MAP3K13). At a concentration of 10 μM, PROTAC LZK-IN-1 facilitates the degradation of LZK and inhibits the expression of p53 and c-MYC, leading to reduced viability of global head and neck squamous cell carcinoma (HNSCC) cell lines. This compound is applicable in anticancer research.
Fórmula:C51H64F2N10O5SCor e Forma:SolidPeso molecular:967.18c-Myc ligand 1
CAS:c-Mycligand 1 is a c-Myc inhibitor and functions as a ligand for target proteins in PROTAC (Proteolysis Targeting Chimeras). It is utilized in the synthesis of PROTAC c-Myc inhibitor 7.Fórmula:C13H10N2O2Peso molecular:226.23sAJM589
CAS:sAJM589 is a Myc inhibitor that dose-dependently disrupts Myc-Max heterodimers, thereby decreasing Myc protein levels and inhibiting the cellular proliferation.Fórmula:C16H10N2OPureza:98%Cor e Forma:SolidPeso molecular:246.26IRES-C11
CAS:IRES-C11 is a specific inhibitor of translation that targets the internal ribosome entry site (IRES) of the c-MYC gene. It functions by blocking the interaction between heterogeneous nuclear ribonucleoprotein A1, a trans-acting factor required for c-MYC IRES activity, and its corresponding IRES. Notably, IRES-C11 does not inhibit the IRES activity of BAG-1, XIAP, and p53.Fórmula:C13H11Cl2NO4Pureza:99.89%Cor e Forma:SolidPeso molecular:316.14Ref: TM-T40419
1mg94,00€5mg222,00€10mg356,00€25mg708,00€50mg1.063,00€100mg1.674,00€200mg2.242,00€1mL*10mM (DMSO)245,00€(S)-10-Hydroxycamptothecin
CAS:(S)-10-Hydroxycamptothecin (10-HCPT) is a DNA topoisomerase I inhibitor, utilized as a clinical therapy agent against hepatoma.Fórmula:C20H16N2O5Pureza:99.09% - 99.81%Cor e Forma:SolidPeso molecular:364.35Agrimol B
CAS:1. Agrimol B is a main active ingredient isolated from Agrimonia pilosa Ledeb.Fórmula:C37H46O12Pureza:99.06% - ≥95%Cor e Forma:SolidPeso molecular:682.75Saxagliptin
CAS:Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.Fórmula:C18H25N3O2Pureza:99.17% - 99.95%Cor e Forma:SolidPeso molecular:315.41Mycro 3
CAS:Mycro 3 is potent and selective for c-Myc in whole cell assays.Fórmula:C24H17ClF2N6O4Pureza:99.51% - 99.61%Cor e Forma:SolidPeso molecular:526.88Ref: TM-T4367
1mg50,00€5mg94,00€10mg165,00€25mg318,00€50mg452,00€100mg627,00€200mg845,00€1mL*10mM (DMSO)110,00€10074-G5
CAS:10074-G5 is an inhibitor of c-Myc-Max dimerization.Fórmula:C18H12N4O3Pureza:99.51% - 99.94%Cor e Forma:SolidPeso molecular:332.31Ref: TM-T3686
2mg39,00€5mg59,00€10mg84,00€25mg135,00€50mg213,00€100mg375,00€200mg535,00€500mg853,00€1mL*10mM (DMSO)65,00€ML327
CAS:ML327 is a MYC blocker. ML327 can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).Fórmula:C19H18N4O4Pureza:98.47%Cor e Forma:SolidPeso molecular:366.37Ref: TM-T4252
1mg47,00€2mg62,00€5mg92,00€10mg137,00€25mg222,00€50mg356,00€100mg612,00€200mg850,00€1mL*10mM (DMSO)101,00€Lusianthridin
CAS:Lusianthridin is a natural product from Dendrobium venustum.Fórmula:C15H14O3Pureza:98.49%Cor e Forma:SolidPeso molecular:242.27NNK
CAS:NNK is a procarcinogen and a major tobacco-specific toxicant. It inhibits the expression of lysyl oxidase which is a tumor suppressor.Cost-effective and quality-assured.Fórmula:C10H13N3O2Pureza:99.63% - 99.92%Cor e Forma:SolidPeso molecular:207.23Ref: TM-T20533
5mg57,00€10mg90,00€25mg150,00€50mg215,00€100mg260,00€200mg385,00€500mg617,00€1mL*10mM (DMSO)62,00€10058-F4
CAS:10058-F4 inhibits c-Myc-Max, blocking c-Myc target gene activation, causing cell-cycle arrest & apoptosis.Fórmula:C12H11NOS2Pureza:98% - 99.87%Cor e Forma:SolidPeso molecular:249.35APTO-253 HCl
CAS:APTO-253 (LOR-253/LT-253) is a small-molecule MTF-1 inhibitor with antitumor properties, reducing cyclin D1, hypoxia, and angiogenesis gene expression.Fórmula:C22H15ClFN5Cor e Forma:SolidPeso molecular:403.8410074-A4
CAS:10074-A4 is a c-Myc binding compound that associates with c-Myc370–409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features fromFórmula:C18H14Cl2N2O3SPureza:99.06%Cor e Forma:SolidPeso molecular:409.29Ref: TM-T9628
1mg56,00€2mg80,00€5mg114,00€10mg177,00€25mg318,00€50mg454,00€100mg627,00€200mg845,00€1mL*10mM (DMSO)101,00€Artemisitene
CAS:Artemisitene, an oxidized antimalarial derivative of Artemisinin, stems from precursors like Artemisinin B and Artemisinic acid.Fórmula:C15H20O5Pureza:99.58%Cor e Forma:SolidPeso molecular:280.32Ref: TM-T21065
1mg95,00€5mg187,00€10mg329,00€25mg560,00€50mg800,00€100mg1.103,00€1mL*10mM (DMSO)281,00€NY2267
CAS:NY2267 (Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethylFórmula:C38H43N3O6Pureza:99.16% - 99.27%Cor e Forma:SolidPeso molecular:637.76BTYNB
CAS:BTYNB (MDK6620) is an inhibitor of the oncofetal mRNA-binding protein IMP1. MDK6620 downregulates β-TrCP1 mRNA and reduces activation of NF-κB.Fórmula:C12H9BrN2OSPureza:≥95%Cor e Forma:SolidPeso molecular:309.18Idarubicin hydrochloride
CAS:Idarubicin hydrochloride (Zavedos), a hydrochloride salt form of Idarubicin, is a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells ( IC50: 3.3 ng/mL).Fórmula:C26H27NO9·HClPureza:98.91% - 99.96%Cor e Forma:SolidPeso molecular:533.95

